Canagliflozin Alternatives in Rhode Island
Compare generic and therapeutic alternatives to Canagliflozin (canagliflozin) available at Rhode Island pharmacies. Save up to 48% on your prescription — no insurance required.
Top Alternatives in Rhode Island
Metformin
therapeutic
First-line T2D medication — dramatically cheaper
Avg cash price: $8/mo
Dapagliflozin (Farxiga)
therapeutic
Competing SGLT2 inhibitor with similar profile
Avg cash price: $530/mo
Empagliflozin (Jardiance)
therapeutic
SGLT2 inhibitor with strong cardiovascular outcomes data
Avg cash price: $560/mo
Rhode Island Prescription Assistance Programs
RIPAE (Rhode Island Pharmaceutical Assistance to the Elderly)
State pharmaceutical assistance program that helped eligible seniors pay for prescription drug co-pays and premiums under Medicare Part D.
Eligibility: Note: RIPAE status should be verified as the program was transitioned following ACA implementation. Contact the RI Division of Elderly Affairs at 1-401-462-3000 for current program availability.
Rhode Island Medicaid (Medicaid and RIte Care)
Prescription drug coverage for Rhode Island Medicaid beneficiaries through managed care.
Eligibility: Low-income Rhode Island adults, children, pregnant women, and people with disabilities.
Frequently Asked Questions
Is there a generic for canagliflozin (Invokana)?
Not yet as of 2025. Canagliflozin is still under brand exclusivity as Invokana. All SGLT2 inhibitors remain brand-only at similar high prices.
How does canagliflozin compare to other SGLT2 inhibitors?
Canagliflozin, dapagliflozin, and empagliflozin have similar glucose-lowering effects. Differences emerge in cardiovascular and renal outcomes data — your cardiologist or endocrinologist guides the choice.
What is the main risk specific to canagliflozin?
Canagliflozin carries an FDA warning about increased risk of lower-limb amputations, particularly in patients with peripheral vascular disease. Discuss your individual risk with your doctor.
Can Script Unlock help with canagliflozin costs?
While there is no generic, Script Unlock pharmacies sometimes offer lower cash-pay brand pricing. It is worth posting your script to compare bids.
Is metformin a good alternative to canagliflozin for T2D?
Metformin is first-line T2D therapy at under $10/month. SGLT2 inhibitors like canagliflozin are added for patients who need additional cardiovascular or renal benefits beyond glucose lowering.